Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

NCT04376528 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis, Autoimmune
Primary Biliary Cholangitis
Immunosuppression

Interventions

DRUG: Cyclosporin A
DRUG: Mycophenolate Mofetil

Sponsor

West China Hospital